|
|
Article: Research company is ordered to give teen experimental drug
- Article from:
- Deseret News (Salt Lake City)
- Article date:
- August 21, 2008
- Author:
-
|
Copyright informationCopyright 2008 Deseret News (Salt Lake City). Provided by ProQuest LLC. (Hide copyright information)
|
NEWARK, N.J. -- A federal judge on Wednesday ordered a research
company to supply an experimental drug to a 16-year-old Minnesota
boy who is terminally ill with a rare form of muscular dystrophy.
The decision offers no immediate relief to Jacob Gunvalson. Due
to federal regulations, the teen cannot begin taking the drug
immediately.
PTC Therapeutics plans to appeal the ruling by U.S. District
Judge William J. Martini, who also denied the company's request to
put his decision on hold while it was appealed.
Jacob's family contends that PTC, of South Plainfield, led them
to believe he could participate in a clinical trial of the drug,
which is being investigated as a possible treatment. But ...